38
New platinum TOC catalysts
Elemental Microanalysis, a leading global supplier to the elemental analysis market, is pleased to release a series of platinum TOC catalysts: B1609, B1610 and B1611.
Developed by Element’s in-house R&D team, these catalysts are intended as direct replacement for the standard platinum catalysts offered by Shimadzu for TOC–L and TOC– V analysers. Elemental’s TOC catalysts use a zirconia support, rather than alumina; there is both a colour and a weight difference when compared to the OEM catalyst.
Elemental’s zirconia catalysts offer advantages over the original OEM catalyst: lower blank values - leading to lower practical limit of quantifi cation; stabilises more quickly - allowing faster conditioning of catalyst when installing a new reaction tube; longer lifetime – offering a greater number of sample runs before replacement; more robust – making it less prone to physical degradation.
In addition to the new TOC catalysts, Elemental Microanalysis offers a large range of consumables for the Shimadzu TOC–L/V series analysers, including: combustion tubes, halogen scrubbers, platinum gauze, O-rings, and other operational accessories.
More information online:
ilmt.co/PL/eNxG 62492pr@reply-direct.com
Automated parallel capillary electrophoresis system simplifi es protein analysis
The Agilent ProteoAnalyzer system is an automated parallel capillary electrophoresis system for protein analysis. This innovative platform simplifi es and enhances the effi ciency of analysing complex protein mixtures, catering to diverse sectors including pharma, biotech, food analysis, and academia.
Capillary electrophoresis (CE) has become a cornerstone in protein separation due to its rapid, high-resolution analysis and minimal sample consumption. With growing interest in monoclonal antibodies and therapeutic protein targets, the demand for CE solutions is on the rise.
The ProteoAnalyzer automates capillary electrophoresis-sodium dodecyl sulfate (CE-SDS) analysis of reduced and non-reduced protein samples. Processing 12 samples in just 30 minutes, it eliminates the cumbersome SDS-PAGE gel preparation, staining/destaining, and analysis, allowing users to focus on results.
With the capability to separate proteins ranging from 10 to 240 kDa in a single run, the system accommodates diverse samples, including monoclonal antibodies, biosimilars, and crude lysates. Individual capillaries are rejuvenated between each separation, ensuring accurate analysis across various sample types.
The ProteoAnalyzer system enhances effi ciency, versatility, and reliability, particularly in protein QC workfl ows. By automating separation, data processing, and simplifying sample preparation, it streamlines analysis workfl ows, reducing training and labour costs. Additionally, it can analyse different sizes and types of proteins in a single run, consistently delivering accurate results and minimising the need for reanalysis.
Knut Wintergerst, Vice President and General Manager of Agilent’s Biomolecular Analysis Division, emphasises the system’s effi ciency, versatility, and reliability, stating that it simplifi es the analysis of complex mixtures across diverse sectors, from pharma to academia.
As a market leader in CE, Agilent’s ProteoAnalyzer strengthens its position as a provider of quality control analysis solutions, extending its CE portfolio across relevant biomolecule classes and catering to the evolving needs of various industries.
More information online:
ilmt.co/PL/G75V 62526pr@reply-direct.com
Send your Press Releases to:
pr@intlabmate.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130 |
Page 131 |
Page 132 |
Page 133 |
Page 134 |
Page 135 |
Page 136 |
Page 137 |
Page 138 |
Page 139 |
Page 140 |
Page 141 |
Page 142 |
Page 143 |
Page 144 |
Page 145 |
Page 146 |
Page 147 |
Page 148
